Treceți offline cu aplicația Player FM !
Wanda Cui on measuring ovarian toxicity
Manage episode 378652720 series 2829082
Dr. Wanda Cui (Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia) discusses her Review on measuring ovarian toxicity in clinical trials.
Read the full article:
https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(23)00390-X/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanonc
Tell us what you thought about this episode
Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
205 episoade
Manage episode 378652720 series 2829082
Dr. Wanda Cui (Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia) discusses her Review on measuring ovarian toxicity in clinical trials.
Read the full article:
https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(23)00390-X/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanonc
Tell us what you thought about this episode
Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
205 episoade
Semua episode
×1 Yannick Romero on the changing landscape of national cancer control plans 24:40
1 M Saiful Huq and Mostafa Aziz Sumon on the series Cancer Care in South Asian Association for Regional Cooperation (SAARC) Countries 22:15
1 Steven Horwitz on valemetostat for relapsed or refractory T-cell lymphoma 15:07
1 Zachary Zumsteg on early phase trial design for novel drug-radiotherapy combination 17:21
1 May Abdel-Wahab and Andrew Scott on The Lancet Oncology Commission on Radiotherapy and Theranostics 40:45
1 Kanwal Raghav on trastuzumab deruxtecan in HER2-positive advanced colorectal cancer (DESTINY-CRC02) 13:22
1 Emmy Boerrigter on dose selection of novel anticancer drugs 11:41
1 Hisham Mehanna and Sue Yom on head and neck cancer consensus recommendations 36:56
1 Garth Strohbehn and Katie Lichter on the environmental impact of cancer treatment 24:08
1 James Shultz, Ana Patricia Ortiz, and Leticia Nogueira on cancer and compounding disasters in the Caribbean 35:05
1 Bernardo Goulart on correlations of endpoints in lung cancer immunotherapy trials 11:22
1 Maria Kyrgiou on innovations in gynaecological cancers and global disparities 25:42
1 Georgios Lyratzopoulos on the use of chemotherapy and radiotherapy in patients with eight common cancers 34:43
1 Mike Sathekge on radioligand therapy of metastatic castration-resistant prostate cancer 16:06
1 Shankar Siva on stereotactic body radiotherapy for primary renal cell carcinoma 13:53
Bun venit la Player FM!
Player FM scanează web-ul pentru podcast-uri de înaltă calitate pentru a vă putea bucura acum. Este cea mai bună aplicație pentru podcast și funcționează pe Android, iPhone și pe web. Înscrieți-vă pentru a sincroniza abonamentele pe toate dispozitivele.